Estimated Glomerular Filtration Rate (eGFR) Slope Assessment as a Surrogate End-point in Cardiovascular trials: Implications, Impediments, and Future Directions
Curr Probl Cardiol
.
2023 Mar;48(3):101508.
doi: 10.1016/j.cpcardiol.2022.101508.
Epub 2022 Nov 17.
Authors
Talal Almas
1
,
Reema Alsufyani
2
,
Riaz Jiffry
2
,
Abdulla K Al Subai
2
,
Abdulla Almesri
2
,
Syed Altamash Ali
3
,
Omar Baqal
4
,
Jahanzeb Malik
5
,
Taha Ahmed
6
,
Mariam Nadeem Rana
7
Affiliations
1
Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address:
[email protected]
.
2
Royal College of Surgeons in Ireland, Dublin, Ireland.
3
Houston Methodist Hospital, Houston, TX.
4
Mayo Clinic, Phoenix, AZ.
5
Cardiovascular Analytics Group, Hong Kong.
6
University of Kentucky, Louisville, KY.
7
University Hospitals Cleveland Medical Centre, Cleveland, OH.
PMID:
36402218
DOI:
10.1016/j.cpcardiol.2022.101508
No abstract available
Publication types
Review
MeSH terms
Biomarkers
Glomerular Filtration Rate
Humans
Renal Insufficiency, Chronic*
Substances
Biomarkers